Industry Research Reports
Home > Reports > Medical Devices & Consumables > Cardiopulmonary Bypass Machine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Cardiopulmonary Bypass Machine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 91 Pages
Report ld: 3482180
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Cardiopulmonary Bypass Machine Market Size(US$)
CAGR 2025-2031
4.5%
Market Size,2031
USD 382
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 293 million
Market Forecast in 2031(Value)
US$ 382 million
CAGR
4.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Cardiopulmonary Bypass Machine was estimated to be worth US$ 282 million in 2024 and is forecast to a readjusted size of US$ 382 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient"s blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
The Cardiopulmonary Bypass Machine market is primarily driven by the increasing prevalence of cardiovascular diseases and the growing demand for advanced surgical procedures. As heart surgeries become more intricate and the complexity of cases rises, the need for reliable and sophisticated cardiopulmonary bypass machines is on the rise. These machines play a crucial role in maintaining circulation and oxygenation during cardiac surgeries, enabling surgeons to perform intricate procedures with precision. Moreover, technological advancements have led to the development of innovative features in these machines, such as improved monitoring, minimized blood trauma, and reduced risk of complications. However, the market also faces challenges, including the high cost of these machines and the need for skilled healthcare professionals to operate them effectively. Regulatory compliance and safety considerations also present challenges for manufacturers. To succeed, stakeholders must focus on continuous innovation, addressing cost concerns through efficient manufacturing processes, and providing comprehensive training and support to healthcare teams. Collaborating with medical institutions to understand their specific needs and enhancing patient outcomes through improved machine performance will drive market growth and the adoption of cardiopulmonary bypass machines.
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Bypass Machine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cardiopulmonary Bypass Machine by region & country, by Type, and by Application.
The Cardiopulmonary Bypass Machine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Bypass Machine.
MARKET SEGMENTATION
By Company
- LivaNova
- Getinge
- Medtronic
- Terumo
- Braile Biomedica
- Tianjin Medical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Single Roller Pump
- Double Roller Pump
Segment by Application
- Cardiac Surgery
- Lung Transplant Operation
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiopulmonary Bypass Machine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cardiopulmonary Bypass Machine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cardiopulmonary Bypass Machine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cardiopulmonary Bypass Machine Product Introduction
1.2 Global Cardiopulmonary Bypass Machine Market Size Forecast
1.2.1 Global Cardiopulmonary Bypass Machine Sales Value (2020-2031)
1.2.2 Global Cardiopulmonary Bypass Machine Sales Volume (2020-2031)
1.2.3 Global Cardiopulmonary Bypass Machine Sales Price (2020-2031)
1.3 Cardiopulmonary Bypass Machine Market Trends & Drivers
1.3.1 Cardiopulmonary Bypass Machine Industry Trends
1.3.2 Cardiopulmonary Bypass Machine Market Drivers & Opportunity
1.3.3 Cardiopulmonary Bypass Machine Market Challenges
1.3.4 Cardiopulmonary Bypass Machine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cardiopulmonary Bypass Machine Players Revenue Ranking (2024)
2.2 Global Cardiopulmonary Bypass Machine Revenue by Company (2020-2025)
2.3 Global Cardiopulmonary Bypass Machine Players Sales Volume Ranking (2024)
2.4 Global Cardiopulmonary Bypass Machine Sales Volume by Company Players (2020-2025)
2.5 Global Cardiopulmonary Bypass Machine Average Price by Company (2020-2025)
2.6 Key Manufacturers Cardiopulmonary Bypass Machine Manufacturing Base and Headquarters
2.7 Key Manufacturers Cardiopulmonary Bypass Machine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cardiopulmonary Bypass Machine
2.9 Cardiopulmonary Bypass Machine Market Competitive Analysis
2.9.1 Cardiopulmonary Bypass Machine Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Cardiopulmonary Bypass Machine Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Bypass Machine as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Single Roller Pump
3.1.2 Double Roller Pump
3.2 Global Cardiopulmonary Bypass Machine Sales Value by Type
3.2.1 Global Cardiopulmonary Bypass Machine Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Cardiopulmonary Bypass Machine Sales Value, by Type (2020-2031)
3.2.3 Global Cardiopulmonary Bypass Machine Sales Value, by Type (%) (2020-2031)
3.3 Global Cardiopulmonary Bypass Machine Sales Volume by Type
3.3.1 Global Cardiopulmonary Bypass Machine Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Cardiopulmonary Bypass Machine Sales Volume, by Type (2020-2031)
3.3.3 Global Cardiopulmonary Bypass Machine Sales Volume, by Type (%) (2020-2031)
3.4 Global Cardiopulmonary Bypass Machine Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cardiac Surgery
4.1.2 Lung Transplant Operation
4.1.3 Other
4.2 Global Cardiopulmonary Bypass Machine Sales Value by Application
4.2.1 Global Cardiopulmonary Bypass Machine Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Cardiopulmonary Bypass Machine Sales Value, by Application (2020-2031)
4.2.3 Global Cardiopulmonary Bypass Machine Sales Value, by Application (%) (2020-2031)
4.3 Global Cardiopulmonary Bypass Machine Sales Volume by Application
4.3.1 Global Cardiopulmonary Bypass Machine Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Cardiopulmonary Bypass Machine Sales Volume, by Application (2020-2031)
4.3.3 Global Cardiopulmonary Bypass Machine Sales Volume, by Application (%) (2020-2031)
4.4 Global Cardiopulmonary Bypass Machine Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Cardiopulmonary Bypass Machine Sales Value by Region
5.1.1 Global Cardiopulmonary Bypass Machine Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Cardiopulmonary Bypass Machine Sales Value by Region (2020-2025)
5.1.3 Global Cardiopulmonary Bypass Machine Sales Value by Region (2026-2031)
5.1.4 Global Cardiopulmonary Bypass Machine Sales Value by Region (%), (2020-2031)
5.2 Global Cardiopulmonary Bypass Machine Sales Volume by Region
5.2.1 Global Cardiopulmonary Bypass Machine Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Cardiopulmonary Bypass Machine Sales Volume by Region (2020-2025)
5.2.3 Global Cardiopulmonary Bypass Machine Sales Volume by Region (2026-2031)
5.2.4 Global Cardiopulmonary Bypass Machine Sales Volume by Region (%), (2020-2031)
5.3 Global Cardiopulmonary Bypass Machine Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Cardiopulmonary Bypass Machine Sales Value, 2020-2031
5.4.2 North America Cardiopulmonary Bypass Machine Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Cardiopulmonary Bypass Machine Sales Value, 2020-2031
5.5.2 Europe Cardiopulmonary Bypass Machine Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Cardiopulmonary Bypass Machine Sales Value, 2020-2031
5.6.2 Asia Pacific Cardiopulmonary Bypass Machine Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Cardiopulmonary Bypass Machine Sales Value, 2020-2031
5.7.2 South America Cardiopulmonary Bypass Machine Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cardiopulmonary Bypass Machine Sales Value, 2020-2031
5.8.2 Middle East & Africa Cardiopulmonary Bypass Machine Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cardiopulmonary Bypass Machine Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Cardiopulmonary Bypass Machine Sales Value
6.2.1 Key Countries/Regions Cardiopulmonary Bypass Machine Sales Value, 2020-2031
6.2.2 Key Countries/Regions Cardiopulmonary Bypass Machine Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Cardiopulmonary Bypass Machine Sales Value, 2020-2031
6.3.2 United States Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Cardiopulmonary Bypass Machine Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Cardiopulmonary Bypass Machine Sales Value, 2020-2031
6.4.2 Europe Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Cardiopulmonary Bypass Machine Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Cardiopulmonary Bypass Machine Sales Value, 2020-2031
6.5.2 China Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
6.5.3 China Cardiopulmonary Bypass Machine Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Cardiopulmonary Bypass Machine Sales Value, 2020-2031
6.6.2 Japan Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Cardiopulmonary Bypass Machine Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Cardiopulmonary Bypass Machine Sales Value, 2020-2031
6.7.2 South Korea Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Cardiopulmonary Bypass Machine Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Cardiopulmonary Bypass Machine Sales Value, 2020-2031
6.8.2 Southeast Asia Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Cardiopulmonary Bypass Machine Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Cardiopulmonary Bypass Machine Sales Value, 2020-2031
6.9.2 India Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
6.9.3 India Cardiopulmonary Bypass Machine Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 LivaNova
7.1.1 LivaNova Company Information
7.1.2 LivaNova Introduction and Business Overview
7.1.3 LivaNova Cardiopulmonary Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 LivaNova Cardiopulmonary Bypass Machine Product Offerings
7.1.5 LivaNova Recent Development
7.2 Getinge
7.2.1 Getinge Company Information
7.2.2 Getinge Introduction and Business Overview
7.2.3 Getinge Cardiopulmonary Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Getinge Cardiopulmonary Bypass Machine Product Offerings
7.2.5 Getinge Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Cardiopulmonary Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Medtronic Cardiopulmonary Bypass Machine Product Offerings
7.3.5 Medtronic Recent Development
7.4 Terumo
7.4.1 Terumo Company Information
7.4.2 Terumo Introduction and Business Overview
7.4.3 Terumo Cardiopulmonary Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Terumo Cardiopulmonary Bypass Machine Product Offerings
7.4.5 Terumo Recent Development
7.5 Braile Biomedica
7.5.1 Braile Biomedica Company Information
7.5.2 Braile Biomedica Introduction and Business Overview
7.5.3 Braile Biomedica Cardiopulmonary Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Braile Biomedica Cardiopulmonary Bypass Machine Product Offerings
7.5.5 Braile Biomedica Recent Development
7.6 Tianjin Medical
7.6.1 Tianjin Medical Company Information
7.6.2 Tianjin Medical Introduction and Business Overview
7.6.3 Tianjin Medical Cardiopulmonary Bypass Machine Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Tianjin Medical Cardiopulmonary Bypass Machine Product Offerings
7.6.5 Tianjin Medical Recent Development
8 Industry Chain Analysis
8.1 Cardiopulmonary Bypass Machine Industrial Chain
8.2 Cardiopulmonary Bypass Machine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cardiopulmonary Bypass Machine Sales Model
8.5.2 Sales Channel
8.5.3 Cardiopulmonary Bypass Machine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Cardiopulmonary Bypass Machine Market Trends
Table 2. Cardiopulmonary Bypass Machine Market Drivers & Opportunity
Table 3. Cardiopulmonary Bypass Machine Market Challenges
Table 4. Cardiopulmonary Bypass Machine Market Restraints
Table 5. Global Cardiopulmonary Bypass Machine Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Cardiopulmonary Bypass Machine Revenue Market Share by Company (2020-2025)
Table 7. Global Cardiopulmonary Bypass Machine Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Cardiopulmonary Bypass Machine Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Cardiopulmonary Bypass Machine Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Cardiopulmonary Bypass Machine Manufacturing Base and Headquarters
Table 11. Key Manufacturers Cardiopulmonary Bypass Machine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Cardiopulmonary Bypass Machine
Table 13. Global Cardiopulmonary Bypass Machine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Bypass Machine as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cardiopulmonary Bypass Machine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Cardiopulmonary Bypass Machine Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Cardiopulmonary Bypass Machine Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Cardiopulmonary Bypass Machine Sales Market Share in Value by Type (2020-2025)
Table 20. Global Cardiopulmonary Bypass Machine Sales Market Share in Value by Type (2026-2031)
Table 21. Global Cardiopulmonary Bypass Machine Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Cardiopulmonary Bypass Machine Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Cardiopulmonary Bypass Machine Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Cardiopulmonary Bypass Machine Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Cardiopulmonary Bypass Machine Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Cardiopulmonary Bypass Machine Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Cardiopulmonary Bypass Machine Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Cardiopulmonary Bypass Machine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Cardiopulmonary Bypass Machine Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Cardiopulmonary Bypass Machine Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Cardiopulmonary Bypass Machine Sales Market Share in Value by Application (2020-2025)
Table 32. Global Cardiopulmonary Bypass Machine Sales Market Share in Value by Application (2026-2031)
Table 33. Global Cardiopulmonary Bypass Machine Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Cardiopulmonary Bypass Machine Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Cardiopulmonary Bypass Machine Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Cardiopulmonary Bypass Machine Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Cardiopulmonary Bypass Machine Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Cardiopulmonary Bypass Machine Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Cardiopulmonary Bypass Machine Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Cardiopulmonary Bypass Machine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Cardiopulmonary Bypass Machine Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Cardiopulmonary Bypass Machine Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Cardiopulmonary Bypass Machine Sales Value by Region (2020-2025) & (%)
Table 44. Global Cardiopulmonary Bypass Machine Sales Value by Region (2026-2031) & (%)
Table 45. Global Cardiopulmonary Bypass Machine Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Cardiopulmonary Bypass Machine Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Cardiopulmonary Bypass Machine Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Cardiopulmonary Bypass Machine Sales Volume by Region (2020-2025) & (%)
Table 49. Global Cardiopulmonary Bypass Machine Sales Volume by Region (2026-2031) & (%)
Table 50. Global Cardiopulmonary Bypass Machine Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Cardiopulmonary Bypass Machine Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Cardiopulmonary Bypass Machine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Cardiopulmonary Bypass Machine Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Cardiopulmonary Bypass Machine Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Cardiopulmonary Bypass Machine Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Cardiopulmonary Bypass Machine Sales Volume, (2026-2031) & (K Units)
Table 57. LivaNova Company Information
Table 58. LivaNova Introduction and Business Overview
Table 59. LivaNova Cardiopulmonary Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. LivaNova Cardiopulmonary Bypass Machine Product Offerings
Table 61. LivaNova Recent Development
Table 62. Getinge Company Information
Table 63. Getinge Introduction and Business Overview
Table 64. Getinge Cardiopulmonary Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Getinge Cardiopulmonary Bypass Machine Product Offerings
Table 66. Getinge Recent Development
Table 67. Medtronic Company Information
Table 68. Medtronic Introduction and Business Overview
Table 69. Medtronic Cardiopulmonary Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Medtronic Cardiopulmonary Bypass Machine Product Offerings
Table 71. Medtronic Recent Development
Table 72. Terumo Company Information
Table 73. Terumo Introduction and Business Overview
Table 74. Terumo Cardiopulmonary Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Terumo Cardiopulmonary Bypass Machine Product Offerings
Table 76. Terumo Recent Development
Table 77. Braile Biomedica Company Information
Table 78. Braile Biomedica Introduction and Business Overview
Table 79. Braile Biomedica Cardiopulmonary Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Braile Biomedica Cardiopulmonary Bypass Machine Product Offerings
Table 81. Braile Biomedica Recent Development
Table 82. Tianjin Medical Company Information
Table 83. Tianjin Medical Introduction and Business Overview
Table 84. Tianjin Medical Cardiopulmonary Bypass Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Tianjin Medical Cardiopulmonary Bypass Machine Product Offerings
Table 86. Tianjin Medical Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Cardiopulmonary Bypass Machine Downstream Customers
Table 90. Cardiopulmonary Bypass Machine Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Cardiopulmonary Bypass Machine Product Picture
Figure 2. Global Cardiopulmonary Bypass Machine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Cardiopulmonary Bypass Machine Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Cardiopulmonary Bypass Machine Sales Volume (2020-2031) & (K Units)
Figure 5. Global Cardiopulmonary Bypass Machine Sales Price (2020-2031) & (US$/Unit)
Figure 6. Cardiopulmonary Bypass Machine Report Years Considered
Figure 7. Global Cardiopulmonary Bypass Machine Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Cardiopulmonary Bypass Machine Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cardiopulmonary Bypass Machine Revenue in 2024
Figure 10. Cardiopulmonary Bypass Machine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Single Roller Pump Picture
Figure 12. Double Roller Pump Picture
Figure 13. Global Cardiopulmonary Bypass Machine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Cardiopulmonary Bypass Machine Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Cardiopulmonary Bypass Machine Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16. Global Cardiopulmonary Bypass Machine Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Cardiopulmonary Bypass Machine Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Cardiac Surgery
Figure 19. Product Picture of Lung Transplant Operation
Figure 20. Product Picture of Other
Figure 21. Global Cardiopulmonary Bypass Machine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Cardiopulmonary Bypass Machine Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Cardiopulmonary Bypass Machine Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 24. Global Cardiopulmonary Bypass Machine Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Cardiopulmonary Bypass Machine Price by Application (2020-2031) & (US$/Unit)
Figure 26. North America Cardiopulmonary Bypass Machine Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Cardiopulmonary Bypass Machine Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Cardiopulmonary Bypass Machine Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Cardiopulmonary Bypass Machine Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Cardiopulmonary Bypass Machine Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Cardiopulmonary Bypass Machine Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Cardiopulmonary Bypass Machine Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Cardiopulmonary Bypass Machine Sales Volume (%), (2020-2031)
Figure 38. United States Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Cardiopulmonary Bypass Machine Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Cardiopulmonary Bypass Machine Sales Value by Application (%), 2024 VS 2031
Figure 44. China Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
Figure 46. China Cardiopulmonary Bypass Machine Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Cardiopulmonary Bypass Machine Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Cardiopulmonary Bypass Machine Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Cardiopulmonary Bypass Machine Sales Value by Application (%), 2024 VS 2031
Figure 56. India Cardiopulmonary Bypass Machine Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Cardiopulmonary Bypass Machine Sales Value by Type (%), 2024 VS 2031
Figure 58. India Cardiopulmonary Bypass Machine Sales Value by Application (%), 2024 VS 2031
Figure 59. Cardiopulmonary Bypass Machine Industrial Chain
Figure 60. Cardiopulmonary Bypass Machine Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 4.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Cardiopulmonary Bypass Machine in 2025?
Which companies rank high in the global Cardiopulmonary Bypass Machine market?
What is the annual compound growth rate of the global Cardiopulmonary Bypass Machine market size from 2025 to 2031?
What was the global market size of Cardiopulmonary Bypass Machine in 2031?
Related Reports
Cardiopulmonary Bypass Machine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cardiopulmonary Bypass Machine was estimated to be worth US$ 293 million in 2025 and is projected to reach US$ 398 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 132
USD 3950.00
(Single User License)
Global Cardiopulmonary Bypass Machine Market Research Report 2026
The global Cardiopulmonary Bypass Machine market was valued at US$ 293 million in 2025 and is anticipated to reach US$ 398 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 110
USD 2900.00
(Single User License)
Global Cardiopulmonary Bypass Machine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cardiopulmonary Bypass Machine market size was US$ 282 million in 2024 and is forecast to a readjusted size of US$ 382 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Global Cardiopulmonary Bypass Machine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cardiopulmonary Bypass Machine market is projected to grow from US$ 282 million in 2024 to US$ 382 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 150
USD 4900.00
(Single User License)
Global Cardiopulmonary Bypass Machine Market Research Report 2025
The global market for Cardiopulmonary Bypass Machine was valued at US$ 282 million in the year 2024 and is projected to reach a revised size of US$ 382 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published Date: 2025-01-16
Pages: 85
USD 2900.00
(Single User License)
Global Cardiopulmonary Bypass Machine Market Insights, Forecast to 2030
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published Date: 2024-04-12
Pages: 95
USD 4900.00
(Single User License)
Global Cardiopulmonary Bypass Machine Market Research Report 2024
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published Date: 2024-01-12
Pages: 78
USD 2900.00
(Single User License)
Cardiopulmonary Bypass Machine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published Date: 2024-01-08
Pages: 100
USD 3950.00
(Single User License)
Cardiopulmonary Bypass Machine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cardiopulmonary Bypass Machine was estimated to be worth US$ 293 million in 2025 and is projected to reach US$ 398 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 132
USD 3950.00 (Single User License)Global Cardiopulmonary Bypass Machine Market Research Report 2026
The global Cardiopulmonary Bypass Machine market was valued at US$ 293 million in 2025 and is anticipated to reach US$ 398 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 110
USD 2900.00 (Single User License)Global Cardiopulmonary Bypass Machine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cardiopulmonary Bypass Machine market size was US$ 282 million in 2024 and is forecast to a readjusted size of US$ 382 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)Global Cardiopulmonary Bypass Machine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cardiopulmonary Bypass Machine market is projected to grow from US$ 282 million in 2024 to US$ 382 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 150
USD 4900.00 (Single User License)Global Cardiopulmonary Bypass Machine Market Research Report 2025
The global market for Cardiopulmonary Bypass Machine was valued at US$ 282 million in the year 2024 and is projected to reach a revised size of US$ 382 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published: 2025-01-16
Pages: 85
USD 2900.00 (Single User License)Global Cardiopulmonary Bypass Machine Market Insights, Forecast to 2030
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published: 2024-04-12
Pages: 95
USD 4900.00 (Single User License)Global Cardiopulmonary Bypass Machine Market Research Report 2024
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published: 2024-01-12
Pages: 78
USD 2900.00 (Single User License)Cardiopulmonary Bypass Machine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation in which the patient's blood is diverted from the heart and lungs and rerouted outside of the body. The normal physiologic functions of the heart and lungs, including circulation of blood, oxygenation, and ventilation, are temporarily taken over by the CPB machine. In most cases, the heart is also separated from the circulation (eg, aortic cross-clamping) and cardioplegia solution is administered to allow the cardiac surgeon to operate on a nonbeating heart in a field largely devoid of blood, while other end organs remain adequately oxygenated and perfused.
Published: 2024-01-08
Pages: 100
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now